{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:18:19Z","timestamp":1790914699374,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T00:00:00Z","timestamp":1464825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinson's Disease"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Induced pluripotent stem cells (iPSCs) are becoming an important source of pre-clinical models for research focusing on neurodegeneration. They offer the possibility for better understanding of common and divergent pathogenic mechanisms of brain diseases. Moreover, iPSCs provide a unique opportunity to develop personalized therapeutic strategies, as well as explore early pathogenic mechanisms, since they rely on the use of patients\u2019 own cells that are otherwise accessible only post-mortem, when neuronal death-related cellular pathways and processes are advanced and adaptive. Neurodegenerative diseases are in majority of unknown cause, but mutations in specific genes can lead to familial forms of these diseases. For example, mutations in the superoxide dismutase 1 gene lead to the motor neuron disease amyotrophic lateral sclerosis (ALS), while mutations in the <jats:italic>SNCA<\/jats:italic> gene encoding for alpha-synuclein protein lead to familial Parkinson\u2019s disease (PD). The generations of libraries of familial human ALS iPSC lines have been described, and the iPSCs rapidly became useful models for studying cell autonomous and non-cell autonomous mechanisms of the disease. Here we report the generation of a comprehensive library of iPSC lines of familial PD and an associated synucleinopathy, multiple system atrophy (MSA). In addition, we provide examples of relevant neural cell types these iPSC can be differentiated into, and which could be used to further explore early disease mechanisms. These human cellular models will be a valuable resource for identifying common and divergent mechanisms leading to neurodegeneration in PD and MSA.<\/jats:p>","DOI":"10.1038\/npjparkd.2016.9","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T01:56:32Z","timestamp":1464832592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Creation of a library of induced pluripotent stem cells from Parkinsonian patients"],"prefix":"10.1038","volume":"2","author":[{"given":"Staffan","family":"Holmqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160\u00e1rka","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Chumarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja A","family":"Puttonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Lebedeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Ruponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Oksanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Djelloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Goldwurm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lagarkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei","family":"Kiselev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Koistinaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Roybon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,2]]},"reference":[{"key":"BFnpjparkd20169_CR1","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045\u20132047 (1997).","journal-title":"Science"},{"key":"BFnpjparkd20169_CR2","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ana.21380","volume":"63","author":"OA Ross","year":"2008","unstructured":"Ross, O. A. et al. Genomic investigation of alpha-synuclein multiplication and Parkinsonism. Ann. Neurol. 63, 743\u2013750 (2008).","journal-title":"Ann. Neurol."},{"key":"BFnpjparkd20169_CR3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1474-4422(03)00662-8","volume":"3","author":"GK Wenning","year":"2004","unstructured":"Wenning, G. K., Colosimo, C., Geser, F. & Poewe, W. Multiple system atrophy. Lancet Neurol. 3, 93\u2013103 (2004).","journal-title":"Lancet Neurol."},{"key":"BFnpjparkd20169_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.stemcr.2015.07.002","volume":"5","author":"M Djelloul","year":"2015","unstructured":"Djelloul, M. et al. Alpha-synuclein expression in the oligodendrocyte lineage: an in vitro and in vivo study using rodent and human models. Stem Cell Rep. 5, 174\u2013184 (2015).","journal-title":"Stem Cell Rep."},{"key":"BFnpjparkd20169_CR5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"BFnpjparkd20169_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1126\/science.1245296","volume":"342","author":"CY Chung","year":"2013","unstructured":"Chung, C. Y. et al. Identification and rescue of alpha-synuclein toxicity in Parkinson patient-derived neurons. Science 342, 983\u2013987 (2013).","journal-title":"Science"},{"key":"BFnpjparkd20169_CR7","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med."},{"key":"BFnpjparkd20169_CR8","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"HJ Lee","year":"2010","unstructured":"Lee, H. J. et al. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 285, 9262\u20139272 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFnpjparkd20169_CR9","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.celrep.2014.05.027","volume":"7","author":"PJ Hallett","year":"2014","unstructured":"Hallett, P. J. et al. Long-term health of dopaminergic neuron transplants in Parkinson's disease patients. Cell Rep. 7, 1755\u20131761 (2014).","journal-title":"Cell Rep."},{"key":"BFnpjparkd20169_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrm2873","volume":"11","author":"P Brundin","year":"2010","unstructured":"Brundin, P., Melki, R. & Kopito, R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat. Rev. Mol. Cell Biol. 11, 301\u2013307 (2010).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFnpjparkd20169_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"BFnpjparkd20169_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/clpt.2011.38","volume":"89","author":"H Inoue","year":"2011","unstructured":"Inoue, H. & Yamanaka, S. The use of induced pluripotent stem cells in drug development. Clin. Pharmacol. Ther. 89, 655\u2013661 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BFnpjparkd20169_CR13","doi-asserted-by":"publisher","first-page":"e110324","DOI":"10.1371\/journal.pone.0110324","volume":"9","author":"NJ Lamas","year":"2014","unstructured":"Lamas, N. J. et al. Neurotrophic requirements of human motor neurons defined using amplified and purified stem cell-derived cultures. PLoS ONE 9, e110324 (2014).","journal-title":"PLoS ONE"},{"key":"BFnpjparkd20169_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1756-6606-7-22","volume":"7","author":"H Okano","year":"2014","unstructured":"Okano, H. & Yamanaka, S. iPS cell technologies: significance and applications to CNS regeneration and disease. Mol. Brain 7, 22 (2014).","journal-title":"Mol. Brain"},{"key":"BFnpjparkd20169_CR15","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3727\/096368914X684079","volume":"24","author":"Y Pomeshchik","year":"2015","unstructured":"Pomeshchik, Y. et al. Transplanted human induced pluripotent stem cell-derived neural progenitor cells do not promote functional recovery of pharmacologically immunosuppressed mice with contusion spinal cord injury. Cell Transplant. 24, 1799\u20131812 (2015).","journal-title":"Cell Transplant."},{"key":"BFnpjparkd20169_CR16","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1089\/adt.2014.592","volume":"12","author":"O Sirenko","year":"2014","unstructured":"Sirenko, O., Hesley, J., Rusyn, I. & Cromwell, E. F. High-content high-throughput assays for characterizing the viability and morphology of human iPSC-derived neuronal cultures. Assay Drug Dev. Technol. 12, 536\u2013547 (2014).","journal-title":"Assay Drug Dev. Technol."},{"key":"BFnpjparkd20169_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.stem.2013.04.003","volume":"12","author":"YM Yang","year":"2013","unstructured":"Yang, Y. M. et al. A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS. Cell Stem Cell 12, 713\u2013726 (2013).","journal-title":"Cell Stem Cell"},{"key":"BFnpjparkd20169_CR18","doi-asserted-by":"publisher","first-page":"141ra190","DOI":"10.1126\/scitranslmed.3003985","volume":"4","author":"O Cooper","year":"2012","unstructured":"Cooper, O. et al. Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease. Sci. Translat. Med. 4, 141ra190 (2012).","journal-title":"Sci. Translat. Med."},{"key":"BFnpjparkd20169_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.stem.2011.01.013","volume":"8","author":"HN Nguyen","year":"2011","unstructured":"Nguyen, H. N. et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 8, 267\u2013280 (2011).","journal-title":"Cell Stem Cell"},{"key":"BFnpjparkd20169_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/stem.1854","volume":"33","author":"Y Ren","year":"2015","unstructured":"Ren, Y. et al. Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons. Stem Cells 33, 68\u201378 (2015).","journal-title":"Stem Cells"},{"key":"BFnpjparkd20169_CR21","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.stemcr.2015.02.019","volume":"4","author":"A Shaltouki","year":"2015","unstructured":"Shaltouki, A. et al. Mitochondrial alterations by PARKIN in dopaminergic neurons using PARK2 patient-specific and PARK2 knockout isogenic iPSC lines. Stem Cell Rep. 4, 847\u2013859 (2015).","journal-title":"Stem Cell Rep."},{"key":"BFnpjparkd20169_CR22","doi-asserted-by":"publisher","first-page":"4028","DOI":"10.1038\/ncomms5028","volume":"5","author":"DC Schondorf","year":"2014","unstructured":"Schondorf, D. C. et al. iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis. Nat. Commun. 5, 4028 (2014).","journal-title":"Nat. Commun."},{"key":"BFnpjparkd20169_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.celrep.2014.10.023","volume":"9","author":"CM Woodard","year":"2014","unstructured":"Woodard, C. M. et al. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease. Cell Rep. 9, 1173\u20131182 (2014).","journal-title":"Cell Rep."},{"key":"BFnpjparkd20169_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.1783","volume":"29","author":"GL Boulting","year":"2011","unstructured":"Boulting, G. L. et al. A functionally characterized test set of human induced pluripotent stem cells. Nat. Biotechnol. 29, 279\u2013286 (2011).","journal-title":"Nat. Biotechnol."},{"key":"BFnpjparkd20169_CR25","doi-asserted-by":"publisher","first-page":"e0118266","DOI":"10.1371\/journal.pone.0118266","volume":"10","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. A comprehensive library of familial human amyotrophic lateral sclerosis induced pluripotent stem cells. PLoS ONE 10, e0118266 (2015).","journal-title":"PLoS ONE"},{"key":"BFnpjparkd20169_CR26","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.3727\/096368912X658764","volume":"22","author":"KA Puttonen","year":"2013","unstructured":"Puttonen, K. A. et al. Improved method of producing human neural progenitor cells of high purity and in large quantities from pluripotent stem cells for transplantation studies. Cell Transplant. 22, 1753\u20131766 (2013).","journal-title":"Cell Transplant."},{"key":"BFnpjparkd20169_CR27","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1016\/j.biocel.2013.05.029","volume":"45","author":"C Qu","year":"2013","unstructured":"Qu, C. et al. Chondrogenic differentiation of human pluripotent stem cells in chondrocyte co-culture. Int. J. Biochem. Cell Biol. 45, 1802\u20131812 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"BFnpjparkd20169_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fncel.2015.00473","volume":"9","author":"KA Puttonen","year":"2015","unstructured":"Puttonen, K. A. et al. Generation of functional neuromuscular junctions from human pluripotent stem cell lines. Front. Cell. Neurosci. 9, 473 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"BFnpjparkd20169_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature09871","volume":"471","author":"SM Hussein","year":"2011","unstructured":"Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58\u201362 (2011).","journal-title":"Nature"},{"key":"BFnpjparkd20169_CR30","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nmeth.1707","volume":"8","author":"MF Pera","year":"2011","unstructured":"Pera, M. F. The proteomes of native and induced pluripotent stem cells. Nat. Methods 8, 807\u2013808 (2011).","journal-title":"Nat. Methods"},{"key":"BFnpjparkd20169_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nature10648","volume":"480","author":"S Kriks","year":"2011","unstructured":"Kriks, S. et al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480, 547\u2013551 (2011).","journal-title":"Nature"},{"key":"BFnpjparkd20169_CR32","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1002\/stem.1152","volume":"30","author":"J Xi","year":"2012","unstructured":"Xi, J. et al. Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 30, 1655\u20131663 (2012).","journal-title":"Stem Cells"},{"key":"BFnpjparkd20169_CR33","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1038\/nprot.2011.405","volume":"6","author":"R Krencik","year":"2011","unstructured":"Krencik, R. & Zhang, S. C. Directed differentiation of functional astroglial subtypes from human pluripotent stem cells. Nat. Protoc. 6, 1710\u20131717 (2011).","journal-title":"Nat. Protoc."},{"key":"BFnpjparkd20169_CR34","doi-asserted-by":"publisher","first-page":"11319","DOI":"10.1038\/srep11319","volume":"5","author":"J Beers","year":"2015","unstructured":"Beers, J. et al. A cost-effective and efficient reprogramming platform for large-scale production of integration-free human induced pluripotent stem cells in chemically defined culture. Sci. Rep. 5, 11319 (2015).","journal-title":"Sci. Rep."},{"key":"BFnpjparkd20169_CR35","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1002\/jcb.24183","volume":"113","author":"MS Rao","year":"2012","unstructured":"Rao, M. S. & Malik, N. Assessing iPSC reprogramming methods for their suitability in translational medicine. J. Cell. Biochem. 113, 3061\u20133068 (2012).","journal-title":"J. Cell. Biochem."},{"key":"BFnpjparkd20169_CR36","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nbt.3070","volume":"33","author":"TM Schlaeger","year":"2015","unstructured":"Schlaeger, T. M. et al. A comparison of non-integrating reprogramming methods. Nat. Biotechnol. 33, 58\u201363 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFnpjparkd20169_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.scr.2015.05.014","volume":"15","author":"S Holmqvist","year":"2015","unstructured":"Holmqvist, S. et al. Generation of human pluripotent stem cell reporter lines for the isolation of and reporting on astrocytes generated from ventral midbrain and ventral spinal cord neural progenitors. Stem Cell Res. 15, 203\u2013220 (2015).","journal-title":"Stem Cell Res."},{"key":"BFnpjparkd20169_CR38","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"BFnpjparkd20169_CR39","doi-asserted-by":"publisher","first-page":"5719","DOI":"10.1091\/mbc.e05-06-0572","volume":"16","author":"CK Taranger","year":"2005","unstructured":"Taranger, C. K. et al. Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell 16, 5719\u20135735 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"BFnpjparkd20169_CR40","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nbt0502-460","volume":"20","author":"AM Hakelien","year":"2002","unstructured":"Hakelien, A. M., Landsverk, H. B., Robl, J. M., Skalhegg, B. S. & Collas, P. Reprogramming fibroblasts to express T-cell functions using cell extracts. Nat. Biotechnol. 20, 460\u2013466 (2002).","journal-title":"Nat. Biotechnol."},{"key":"BFnpjparkd20169_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409\u2013412 (2011).","journal-title":"Nat. Methods"},{"key":"BFnpjparkd20169_CR42","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.stem.2010.08.012","volume":"7","author":"L Warren","year":"2010","unstructured":"Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618\u2013630 (2010).","journal-title":"Cell Stem Cell"},{"key":"BFnpjparkd20169_CR43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1126\/science.1239278","volume":"341","author":"P Hou","year":"2013","unstructured":"Hou, P. et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651\u2013654 (2013).","journal-title":"Science"},{"key":"BFnpjparkd20169_CR44","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cell.2013.11.009","volume":"155","author":"SD Ryan","year":"2013","unstructured":"Ryan, S. D. et al. Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1alpha transcription. Cell 155, 1351\u20131364 (2013).","journal-title":"Cell"},{"key":"BFnpjparkd20169_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.nbd.2013.10.013","volume":"62","author":"LH Sanders","year":"2014","unstructured":"Sanders, L. H. et al. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: reversal by gene correction. Neurobiol. Dis. 62, 381\u2013386 (2014).","journal-title":"Neurobiol. Dis."},{"key":"BFnpjparkd20169_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nature13800","volume":"515","author":"SH Choi","year":"2014","unstructured":"Choi, S. H. et al. A three-dimensional human neural cell culture model of Alzheimer's disease. Nature 515, 274\u2013278 (2014).","journal-title":"Nature"},{"key":"BFnpjparkd20169_CR47","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nprot.2015.065","volume":"10","author":"YH Kim","year":"2015","unstructured":"Kim, Y. H. et al. A 3D human neural cell culture system for modeling Alzheimer's disease. Nat. Protoc. 10, 985\u20131006 (2015).","journal-title":"Nat. Protoc."},{"key":"BFnpjparkd20169_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pasca","year":"2015","unstructured":"Pasca, A. M. et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671\u2013678 (2015).","journal-title":"Nat. Methods"},{"key":"BFnpjparkd20169_CR49","doi-asserted-by":"publisher","first-page":"3088","DOI":"10.1002\/stem.1823","volume":"32","author":"N Avaliani","year":"2014","unstructured":"Avaliani, N. et al. Optogenetics reveal delayed afferent synaptogenesis on grafted human-induced pluripotent stem cell-derived neural progenitors. Stem Cells 32, 3088\u20133098 (2014).","journal-title":"Stem Cells"},{"key":"BFnpjparkd20169_CR50","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/mt.2015.106","volume":"23","author":"J Doerr","year":"2015","unstructured":"Doerr, J. et al. Arylsulfatase A overexpressing human ipsc-derived neural cells reduce cns sulfatide storage in a mouse model of metachromatic leukodystrophy. Mol. Ther. 23, 1519\u20131531 (2015).","journal-title":"Mol. Ther."},{"key":"BFnpjparkd20169_CR51","doi-asserted-by":"publisher","first-page":"e0129881","DOI":"10.1371\/journal.pone.0129881","volume":"10","author":"J Qin","year":"2015","unstructured":"Qin, J. et al. Transplantation of induced pluripotent stem cells alleviates cerebral inflammation and neural damage in hemorrhagic stroke. PLoS ONE 10, e0129881 (2015).","journal-title":"PLoS ONE"},{"key":"BFnpjparkd20169_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.nbd.2015.04.003","volume":"79","author":"LH Thompson","year":"2015","unstructured":"Thompson, L. H. & Bjorklund, A. Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells. Neurobiol. Dis. 79, 28\u201340 (2015).","journal-title":"Neurobiol. Dis."},{"key":"BFnpjparkd20169_CR53","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1093\/brain\/awt278","volume":"136","author":"D Tornero","year":"2013","unstructured":"Tornero, D. et al. Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain 136, 3561\u20133577 (2013).","journal-title":"Brain"},{"key":"BFnpjparkd20169_CR54","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.stem.2012.12.002","volume":"12","author":"S Wang","year":"2013","unstructured":"Wang, S. et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 12, 252\u2013264 (2013).","journal-title":"Cell Stem Cell"},{"key":"BFnpjparkd20169_CR55","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.stemcr.2013.10.011","volume":"1","author":"J Mertens","year":"2013","unstructured":"Mertens, J. et al. APP processing in human pluripotent stem cell-derived neurons is resistant to NSAID-based gamma-secretase modulation. Stem Cell Rep. 1, 491\u2013498 (2013).","journal-title":"Stem Cell Rep."},{"key":"BFnpjparkd20169_CR56","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.stemcr.2015.10.011","volume":"5","author":"KJ Brennand","year":"2015","unstructured":"Brennand, K. J. et al. Creating patient-specific neural cells for the in vitro study of brain disorders. Stem Cell Rep. 5, 933\u2013945 (2015).","journal-title":"Stem Cell Rep."},{"key":"BFnpjparkd20169_CR57","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/nmeth.3507","volume":"12","author":"D Paull","year":"2015","unstructured":"Paull, D. et al. Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells. Nat. Methods 12, 885\u2013892 (2015).","journal-title":"Nat. Methods"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjparkd20169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjparkd20169","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjparkd20169.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T12:10:13Z","timestamp":1672834213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjparkd20169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,2]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,1]]}},"alternative-id":["BFnpjparkd20169"],"URL":"https:\/\/doi.org\/10.1038\/npjparkd.2016.9","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,2]]},"assertion":[{"value":"23 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16009"}}